Skip to main navigation Skip to search Skip to main content

Central serous chorioretinopathy: A complication of glucocorticoid excess

  • Jaime Levy*
  • , Mira Marcus
  • , Richard Sobel
  • , Tova Lifshitz
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Central serous chorioretinopathy (CSCR) is a disorder characterized by the accumulation of subretinal fluid at the posterior pole of the fundus resulting in diminished visual acuity and distortions of visual perception. Although most reported cases are idiopathic, CSCR is also a recognized rare complication of the hypercortisolemia of pituitary-adrenal disease or, more commonly, of exposure to synthetic corticosteroids or adrenocorticotrophic hormone. When CSCR is related to steroid exposure, significant improvement is anticipated if steroid levels are restored to normal. Irreversible visual damage can occur if corticosteroid therapy is continued. We describe the cases of steroid-related instances of CSCR that have been reported in the English-language, peer-reviewed journals since 1966 (when the connection was first noted) and 2 additional patients we have encountered, 1 with asthma, the other with endocrine orbitopathy.

Original languageEnglish
Pages (from-to)307-309
Number of pages3
JournalEndocrinologist
Volume14
Issue number6
DOIs
StatePublished - Nov 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Central serous chorioretinopathy
  • Complication
  • Glucocorticoids

Fingerprint

Dive into the research topics of 'Central serous chorioretinopathy: A complication of glucocorticoid excess'. Together they form a unique fingerprint.

Cite this